Teufel, A., Gerken, M., Hartl, J., Itzel, T., Fichtner-Feigl, S., Stroszczynski, C., . . . Klinkhammer-Schalke, M. (2015). Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer. BMC Cancer.
Style de citation ChicagoTeufel, Andreas, Michael Gerken, Janine Hartl, Timo Itzel, Stefan Fichtner-Feigl, Christian Stroszczynski, Hans Jürgen Schlitt, Ferdinand Hofstädter, et Monika Klinkhammer-Schalke. "Benefit of Adjuvant Chemotherapy in Patients With T4 UICC II Colon Cancer." BMC Cancer 2015.
Style de citation MLATeufel, Andreas, et al. "Benefit of Adjuvant Chemotherapy in Patients With T4 UICC II Colon Cancer." BMC Cancer 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.